<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The level of basic fibroblast growth factor (bFGF) in cerebrospinal fluid (CF) was measured by an EIA in 15 patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e>, in 11 patients with <z:e sem="disease" ids="C0543822" disease_type="Disease or Syndrome" abbrv="">atherosclerotic occlusive disease</z:e>, and in 8 patients with spinal disc disease </plain></SENT>
<SENT sid="1" pm="."><plain>In the <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> patients, bFGF was found in 13 out of 15 CF samples with a mean value of 101 pg/ml </plain></SENT>
<SENT sid="2" pm="."><plain>However, bFGF was detected in only 4 out of 11 patients with atherosclerotic disease with a mean of 8 pg/ml </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> the patients with disc disease, bFGF was not detected </plain></SENT>
<SENT sid="4" pm="."><plain>The elevated level of bFGF may play a crucial role in the pathogenesis of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
</text></document>